期刊
HAUTARZT
卷 69, 期 1, 页码 64-66出版社
SPRINGER
DOI: 10.1007/s00105-017-4071-8
关键词
Psoriasis; Drug side effects; Biological products; Steroids; Ustekinumab
类别
We report about a 52-year-old woman with onset of drug-induced lupus erythematosus (DILE) in sun-exposed areas, under therapy with secukinumab. Topical therapy with a steroid class 3 for 4 weeks showed substantial improvement. The systemic therapy was switched to ustekinumab. DILE is a rare but notable side effect of biologicals in 0.5-1% of the patients and also possible under therapy with IL-17 inhibition. Switch of the biological agent is necessary in most cases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据